Revvity Change in Accounts Receivable 2010-2025 | RVTY

Revvity change in accounts receivable for the twelve months ending June 30, 2025 was $0.014B, a 46.76% decline year-over-year.

  • Revvity annual change in accounts receivable for 2024 was $-0.016B, a 77.49% increase from 2023.
  • Revvity annual change in accounts receivable for 2023 was $-0.009B, a 113.61% decline from 2022.
  • Revvity annual change in accounts receivable for 2022 was $0.066B, a 60.09% decline from 2021.

Revvity Change in Accounts Receivable 2010-2025 | RVTY

  • Revvity annual change in accounts receivable for 2024 was $-0.016B, a 77.49% increase from 2023.
  • Revvity annual change in accounts receivable for 2023 was $-0.009B, a 113.61% decline from 2022.
  • Revvity annual change in accounts receivable for 2022 was $0.066B, a 60.09% decline from 2021.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$143.6B
CVS Health (CVS)$83.1B
Elevance Health (ELV)$66.2B
Cencora (COR)$55.3B
DiDi Global (DIDIY)$26.1B
Labcorp Holdings (LH)$22.1B
Natera (NTRA)$20.7B
BioMerieux (BMXMF)$17.7B
EUROFINS SCIENT (ERFSF)$14.9B
CochLear (CHEOY)$13.2B
ICON (ICLR)$12.8B
Solventum (SOLV)$12.7B
Medpace Holdings (MEDP)$12.2B
Viatris (VTRS)$11.4B
Sonic Healthcare (SKHHY)$9B
HealthEquity (HQY)$8B
Avantor (AVTR)$7.8B
Caris Life Sciences,�Inc (CAI)$7.6B
Charles River Laboratories (CRL)$7.3B
Bausch + Lomb (BLCO)$4.8B
Sotera Health (SHC)$4B
Amplifon S.p.A (AMFPF)$3.9B
BrightSpring Health Services (BTSG)$3.7B
Surgery Partners (SGRY)$3B
GeneDx Holdings (WGS)$3B
Alignment Healthcare (ALHC)$2.9B
Concentras Parent (CON)$2.8B
Organon (OGN)$2.4B
Progyny (PGNY)$2B
Premier (PINC)$1.9B